“Biological Evaluation of 2,3-Dioxoindolin-N-Phenylacetamide Derivatives As Potent CDC25B and PTP1B Phosphatase Inhibitors”. Brazilian Journal of Pharmaceutical Sciences 56 (December 9, 2020): e00222. Accessed May 8, 2024. https://www.revistas.usp.br/bjps/article/view/181157.